# Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction?

> **NCT03963115** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mahidol University** · enrollment: 17 (actual)

## Conditions studied

- Injection Reactions Site
- Systemic Reactions

## Interventions

- **DRUG:** Epinephrine or normal saline

## Key facts

- **NCT ID:** NCT03963115
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-24
- **Primary completion:** 2019-08-25
- **Final completion:** 2019-09-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963115, "Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03963115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*